A Review of Current and Prospective Treatments for Channelopathies, with a Focus on Gene and Protein Therapy
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
1341-1360
Author(s):
Monica Sakla, Ulrike Breitinger, Hans-Georg Breitinger, Samar Mansour and Salma Nabil Tammam*
Why do Athletes Develop Very Severe or Fatal Forms of COVID after Intense Exercise Following SARS-CoV-2 Infection or Anti-COVID Vaccination?
Journal:
Infectious Disorders - Drug Targets
Volume:
23
Page:
11-15
Author(s):
Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros and Jean-Marc Sabatier*
Biomarkers in Hypertension and Hypertension-related Disorders
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
3846-3879
Author(s):
Patrícia de Carvalho Ribeiro, Lucas Felipe Oliveira, Daniel Mendes Filho, Ricardo Cambraia Parreira, Mariana Sousa Vieira, Bruno Lemes Marques, Elis Marra da Madeira Freitas, Walison N. Silva, Helton da Costa Santiago, Alexander Birbrair, Henning Ulrich, Valdo José Dias da Silva and Rodrigo R. Resende*
Chlorogenic Acid: A Dietary Phenolic Acid with Promising Pharmacotherapeutic Potential
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
3905-3926
Author(s):
Amit Kumar Singh, Rajeev Kumar Singla and Abhay Kumar Pandey*
Advancements in COVID-19 Testing: An In-depth Overview
Journal:
Current Pharmaceutical Biotechnology
Volume:
24
Page:
1122-1148
Author(s):
Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Mehboobali Pannipara, Githa Elizabeth Mathew and Bijo Mathew*
Three Generation β-Blockers for Atrial Fibrillation Treatment
Journal:
Current Hypertension Reviews
Volume:
19
Page:
34-41
Author(s):
Arthur C. Francisco, Wanessa M. C. Awata, Thauann S. Lima, Simone R. Potje, Clare C. Prohaska, Carla S. Ceron and Gabriel T. do Vale*
Involvement of Metabolites and Non-coding RNAs in Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
24
Page:
889-912
Author(s):
Kubra A. Coskun, Bercem Yeman Kıyak, Kezban Ucar Cifci, Elif Kadioglu, Nazlican Yurekli and Yusuf Tutar*
The Emerging Role of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
481-493
Author(s):
Mauro Gitto, Alessandro Villaschi, Massimo Federici, Gianluigi Condorelli and Giulio G. Stefanini*
The Role of Exercise-based Cardiac Rehabilitation in Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
494-501
Author(s):
Jeanne Shan Yin Ong, Weiqin Lin and Tee Joo Yeo*
Cerebral Vasospasm: Practical Review of Diagnosis and Management
Journal:
Reviews on Recent Clinical Trials
Volume:
18
Page:
12-18
Author(s):
Tatsiana Romenskaya*, Yaroslava Longhitano, Fabio Piccolella, Jack Marshall Berger, Marco Artico, Samanta Taurone, Antonio Maconi, Angela Saviano, Michela Caramuta, Gabriele Savioli and Christian Zanza